Mayukh Sukhatme
CIK 1750050 · View on SEC EDGAR ↗
First SEC filing: Oct. 1, 2021 · Latest: Oct. 1, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | ROIV | S | 105,141 | $36.59 | $3,847,109 | 18,630,739 Direct | -0.56% | Disposed | 1.1% (price as of 2026-08-21) |
| Aug. 18, 2026 | ROIV | S | 31,801 | $37.18 | $1,182,361 | 18,630,739 Direct | -0.17% | Disposed | -0.5% (price as of 2026-08-21) |
| Aug. 17, 2026 | ROIV | S | 284,707 | $36.25 | $10,320,629 | 18,630,739 Direct | -1.51% | Disposed | 2.1% (price as of 2026-08-21) |
| Aug. 14, 2026 | ROIV | S | 243,177 | $36.23 | $8,810,303 | 18,630,739 Direct | -1.29% | Disposed | 2.2% (price as of 2026-08-21) |
| June 26, 2026 | ROIV | S | 500,000 | $34.08 | $17,040,000 | 18,677,617 Direct | -2.61% | Disposed | 8.6% (price as of 2026-08-21) |
| June 25, 2026 | ROIV | S | 500,000 | $34.13 | $17,065,000 | 18,677,617 Direct | -2.61% | Disposed | 8.4% (price as of 2026-08-21) |
| Dec. 31, 2025 | ROIV | S | 1,018,995 | $21.71 | $22,122,381 | 20,267,429 Direct | -4.79% | Disposed | 70.5% (price as of 2026-08-21) |
| Dec. 29, 2025 | ROIV | S | 311,873 | $21.74 | $6,780,119 | 19,273,032 Direct | -1.59% | Disposed | 70.2% (price as of 2026-08-21) |
| Dec. 17, 2025 | ROIV | S | 26,831 | $23.09 | $619,528 | 18,869,229 Direct | -0.14% | Disposed | 60.3% (price as of 2026-08-21) |
| Dec. 26, 2024 | ROIV | S | 689,495 | $12.01 | $8,280,835 | 18,836,547 Direct | -3.53% | Disposed | 208.2% (price as of 2026-08-21) |
| Dec. 24, 2024 | ROIV | S | 185,946 | $12.00 | $2,231,352 | 18,836,547 Direct | -0.98% | Disposed | 208.4% (price as of 2026-08-21) |
| Dec. 23, 2024 | ROIV | S | 10,796 | $12.00 | $129,552 | 18,836,547 Direct | -0.06% | Disposed | 208.4% (price as of 2026-08-21) |
| Dec. 18, 2024 | ROIV | S | 412,584 | $12.05 | $4,971,637 | 18,836,547 Direct | -2.14% | Disposed | 207.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | ROIV | Common Shares | Common Shares (136,942) | $3.85 | April 19, 2032 | 136,942 | Disposed |
| Aug. 17, 2026 | ROIV | Common Shares | Common Shares (284,707) | $3.85 | April 19, 2032 | 284,707 | Disposed |
| Aug. 14, 2026 | ROIV | Common Shares | Common Shares (243,177) | $3.85 | April 19, 2032 | 243,177 | Disposed |
| June 26, 2026 | ROIV | Stock Option (Right to Buy) | Common Stock (500,000) | $3.85 | April 19, 2032 | 500,000 | Disposed |
| June 25, 2026 | ROIV | Stock Option (Right to Buy) | Common Stock (500,000) | $3.85 | April 19, 2032 | 500,000 | Disposed |
| Dec. 31, 2025 | ROIV | Stock Option (Right to Buy) | Common Shares (2,449,877) | $12.68 | March 31, 2026 | 2,449,877 | Disposed |
| Dec. 29, 2025 | ROIV | Stock Option (Right to Buy) | Common Shares (748,358) | $12.68 | March 31, 2026 | 748,358 | Disposed |
| Dec. 17, 2025 | ROIV | Common Shares | Common Shares (59,513) | $12.68 | March 31, 2026 | 59,513 | Disposed |
| Dec. 26, 2024 | ROIV | Stock Option (Right to Buy) | Common Stock (689,495) | $3.85 | April 19, 2032 | 689,495 | Disposed |
| Dec. 24, 2024 | ROIV | Stock Option (Right to Buy) | Common Stock (185,946) | $3.85 | April 19, 2032 | 185,946 | Disposed |
| Dec. 23, 2024 | ROIV | Stock Option (Right to Buy) | Common Stock (10,796) | $3.85 | April 19, 2032 | 10,796 | Disposed |
| Dec. 18, 2024 | ROIV | Stock Option (Right to Buy) | Common Stock (412,584) | $3.85 | April 19, 2032 | 412,584 | Disposed |
| March 30, 2024 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 1,856,163 | Disposed |
| Dec. 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 28,411 | Disposed |
| Dec. 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 159,100 | Disposed |
| Sept. 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 28,411 | Disposed |
| Sept. 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 53,033 | Disposed |
| Aug. 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 53,033 | Disposed |
| July 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 106,067 | Disposed |
| May 27, 2023 | ROIV | Capped Value Appreciation Rights | Common Shares | — | March 31, 2026 | 318,199 | Disposed |
| April 20, 2022 | ROIV | Stock Option (Right to Buy) | Common Shares (16,523,184) | $3.85 | April 19, 2032 | 16,523,184 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 1, 2021 | ROIV | Common Shares | 3,024,725 | Direct |
| Oct. 1, 2021 | ROIV | Common Shares | 1,657,698 | Indirect |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (3,657,750) | 3,657,750 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (3,909,306) | 3,909,306 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (1,969,554) | 1,969,554 | Direct |
| Oct. 1, 2021 | ROIV | Capped Value Appreciation Rights→ Common Shares (1,363,711) | 1,363,711 | Direct |
| Oct. 1, 2021 | ROIV | Capped Value Appreciation Rights→ Common Shares | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ROIV
M.D. President and Chief Investment Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $450,000 | $1,243,500 | — | $47,206,737 | — | — | $25,346 | $48,925,582 |
| 2021 | $450,000 | $441,000 | — | $16,578,239 | — | — | $19,186 | $17,488,425 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.